Source link : https://newshealth.biz/health-news/car-t-immune-toxicity-linked-to-non-relapse-mortality-risk-in-myeloma/
(MedPage Today) — Chimeric antigen receptor (CAR) T-cell therapy-associated immune-related adverse events (CirAEs) were associated with a high rate of non-relapse mortality in patients with multiple myeloma, according to a retrospective study… Source link : https://www.medpagetoday.com/hematologyoncology/myeloma/119503 Author : Publish date : 2026-01-20 21:07:00 Copyright for syndicated content belongs to the linked Source.
The post CAR-T Immune Toxicity Linked to Non-Relapse Mortality Risk in Myeloma first appeared on News Health.
—-
Author : News Health
Publish date : 2026-01-20 21:07:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8